School of Chinese Medicine
The development of chitosan based microcapsules as delivery vehicles for orally administered daunorubicin
This study reports the use of chitosan microcapsules for daunorubicin delivery via an oral route. The potential oral delivery of the daunorubicin/chitosan microcapsules was examined using an in vivo athymic nude mice xenograft model with Non-Hodgkin's lymphoma cells. Microencapsulated daunorubicin could be administered orally with tumour growth inhibition activity. © 2014 The Royal Society of Chemistry.
Source Publication Title
Royal Society of Chemistry
Link to Publisher's Edition
Lam, P., Lee, K., Ho, Y., Wong, R., Tong, S., Cheng, C., Lam, K., Tang, J., Bian, Z., Gambari, R., Kok, S., & Chui, C. (2014). The development of chitosan based microcapsules as delivery vehicles for orally administered daunorubicin. RSC Advances, 4 (27), 14109-14114. https://doi.org/10.1039/c4ra00195h